COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,281 Articles (22,759 medRxiv, 8,522 bioRxiv)

Most recent first Previous |  Page 2366: Articles 23651-23660  | Next

Trends in Covid-19 risk-adjusted mortality rates in a single health system
Horwitz, L., Jones, S. A., Cerfolio, R. J., Francois, F., Greco, J., Rudy, B., Petrilli, C. M.
10.1101/2020.08.11.20172775 — Posted: 2020-08-14 Discussion: Onsite
Infodemiological study of COVID-19 in Latin America and The Caribbean
Aragon-Ayala, C. J., Copa-Uscamayta, J., Herrera, L., Zela-Coila, F., Quispe-Juli, C. U.
10.1101/2020.08.11.20173054 — Posted: 2020-08-14
Federated Learning of Electronic Health Records Improves Mortality Prediction in Patients Hospitalized with COVID-19
Vaid, A., Jaladanki, S. K., Xu, J., Teng, S., Kumar, A., Lee, S., Somani, S., Paranjpe, I., De Freitas, J. K., Wanyan, T., Johnson, K. W., Bicak, M., Klang, E., Kwon, Y. J., Costa, A., Zhao, S., Miotto, R., Charney, A. W., Böttinger, E., Fayad, Z. A., Nadkarni, G. N., Wang, F., Glicksberg, B. S.
10.1101/2020.08.11.20172809 — Posted: 2020-08-14
Development of a standards-based city-wide health information exchange for public health in response to COVID-19
Hota, B., Casey, P., McIntyre, A. F., Khan, J., Rab, S., Chopra, A., Lateef, O., Layden, J. E.
10.1101/2020.08.12.20173559 — Posted: 2020-08-14
ACE2 expression in adipose tissue is associated with COVID-19 cardio-metabolic risk factors and cell type composition
El-Sayed Moustafa, J. S., Jackson, A. U., Brotman, S. M., Guan, L., Villicana, S., Roberts, A. L., Zito, A., Bonnycastle, L., Erdos, M. R., Narisu, N., Stringham, H. M., Welch, R., Yan, T., Lakka, T., Parker, S., Tuomilehto, J., Collins, F. S., Pajukanta, P., Boehnke, M., Koistinen, H. A., Laakso, M., Falchi, M., Bell, J. T., Scott, L. J., Mohlke, K. L., Small, K. S.
10.1101/2020.08.11.20171108 — Posted: 2020-08-14
The Status and Risk Factors of COVID-19 Related Suicides in Bangladesh
Boshra, S. N., Islam, M. M.
10.1101/2020.08.11.20171272 — Posted: 2020-08-14
Neutralizing antibodies correlate with protection from SARS-CoV-2 in humans during a fishery vessel outbreak with high attack rate
Addetia, A., Crawford, K. H., Dingens, A., Zhu, H., Roychoudhury, P., Huang, M., Jerome, K. R., Bloom, J. D., Greninger, A.
10.1101/2020.08.13.20173161 — Posted: 2020-08-14 Discussion: Onsite
Immunoreactive peptide maps of SARS-CoV-2 and other human coronaviruses
Mishra, N., Huang, X., Joshi, S., Guo, C., Ng, J., Thakkar, R., Wu, Y., Dong, X., Li, Q., Pinapati, R., Sullivan, E., Caciula, A., Tokarz, R., Briese, T., Lu, J., Lipkin, W. I.
10.1101/2020.08.13.249953 — Posted: 2020-08-14
Furin cleavage of SARS-CoV-2 Spike promotes but is not essential for infection and cell-cell fusion
Papa, G., Mallery, D., Albecka, A., Welch, L., Cattin-Ortola, J., Luptak, J., Paul, D., McMahon, H., Goodfellow, I. G., Carter, A. P., Munro, S. P., James, L. C.
10.1101/2020.08.13.243303 — Posted: 2020-08-14
Metaviromic identification of genetic hotspots of coronavirus pathogenicity using machine learning
Park, J. J., Chen, S.
10.1101/2020.08.13.248575 — Posted: 2020-08-14

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).